News
Ring Therapeutics Presents Promising New Data on its AnelloBricks Biomanufacturing Platform at ASCGT
Ring Therapeutics says it has demonstrated the ability to encapsidate nucleic acid payloads through in vitro assembly.
Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...
Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies into the clinic.
Deb Hart; Head, Investor Relations; Maravai LifeSciences Holdings Inc. William Martin; Chief Executive Officer; Maravai LifeSciences Holdings Inc. Kevin Herde; Chief ...
AnelloBricks is a promising in vitro approach to producing a new class of functional viral vectors, offering dramatic ...
Good afternoon, everyone, and welcome to the Maravai LifeSciences Q1 2025 Results Earnings Call. [Operator Instructions] Also, today's call is being recorded. [Operator Instructions] At this time, ...
The majority of RNAs in each of our cells don't code for any of the thousands of proteins that make up our bodies. Instead, ...
The prospectus describes RBD4059, one of Ribo Life's core candidate products, as the world's first and most advanced siRNA ...
Return on Equity (ROE): Co-Diagnostics's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -18.68%, the company showcases efficient use ...
Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting
In addition, three leading contract development and manufacturing organizations (CDMOs) are presenting data on the performance of Codexis’ double-stranded RNA ligases to combine short RNA fragments, ...
Mana.bio, a biotechnology company leveraging artificial intelligence (AI) and nanotechnology for targeted RNA delivery, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results